As there is an increased use of AI in clinic, real-time prediction based on clinical metrics we already gather (symptoms and vitals) may allow for early identification of high-risk patients and personalized toxicity management/screening.
Utilizing natural language processing, modeling which incorporated real-time clinical on-treatment variables predicted development of radiation pneumonitis post chemoRT in advanced lung cancer. @eClinicalMed@TischCancer@QuadShotNews
https://t.co/74bd6MFRET
Congratulations to the winners of the 2026 Publication Excellence Awards!
Join Speed of Light – The ASTRO Foundation in recognizing these emerging leaders in radiation oncology during the Research Honors presentation at 9:00 a.m. on Mon., Sep. 28, before the keynote address at #ASTRO26 in Boston.
Learn more about the winners: https://t.co/0gCgEFSW6J
@karamarieruicci@ZihangChenMD@Jalal_Ahmed
Voting for the ASCO election is now open! I am honored to be running as one of the candidates for the Designated Radiation Oncologist seat on the Board of Directors. Visit https://t.co/XPxOFR0twa to learn more about the candidates and place your vote!
Juliane Horner-Rieber presented a timely systematic review & meta-analysis comparing moderate hypofractionation vs 2 Gy/fx for RNI & PMRT #ASTRO25
🟰 Oncological outcomes
🔒 Comparable safety
✅ Moderate hypo standard of care
#radonc#breastcancer#OncoAlert@OncoAlert
*Radiation Oncology applicants*
Please join us for a virtual meet and greet:
*Tuesday, August 26 at 7 pm EST*
*Thursday, September 18 at 7 pm EST*
Please sign up below!
@ARRO_org@Inside_TheMatch
New insights on SBRT in recurrent ovarian cancer – now in CTRO:
“SBRT in recurrent oligometastatic ovarian cancer: An EORTC Y-ECI GCG systematic review”
👉 https://t.co/AbnJgiAnoH
🎯 Local control
⏳ Delayed systemic therapy
⚖️ Personalized strategy
@EORTC
⚡️⚡️NEW STUDY - presented today at #ARS2025 in an oral talk by MS2 Yarelis Roque-Reyes from UCC School of Medicine, PR
🧠💥 Does whole brain RT (WBRT) help patients hospitalized with symptomatic leptomeningeal disease (LMD)?
Our @MountSinaiRO study suggests: rarely — and in reality, it may be more harmful to patients’ quality of life and end-of-life care.
🧵👇 #radonc #neuroonc #endoflifecare #ARS2025
LMD is a devastating CNS complication with 3–6 mo survival. WBRT is often used for palliation — but for patients sick enough to need hospital admission, we asked:
👉 Does it actually help?
We reviewed 58 such patients (2014–2023). Here’s what we found ⬇️
📊 Symptom response after WBRT:
❌ 74% worsened
➖ 21% no change
✅ Only 5% improved
💀 Short-term mortality:
40% at 30 days
60% at 60 days
76% at 90 days
📉 ECOG declined in 79%
⏳ 30% spent >⅓ of their remaining lifespan on treatment — often in the hospital
🎯 Our takeaways
➡️ In hospitalized patients with symptomatic LMD, WBRT provides little to no clinical benefit
➡️ with few exceptions, best supportive care — not burdensome WBRT — should be the priority
➡️time to rethink WBRT in hospitalized pts with LMD?
👏 Congrats to Yarelis Roque-Reyes on her #ARS2025 oral talk!
@sindhu_kunal@MountSinaiRO@QuadShotNews
One of our chief residents @DanielDickstein presented his work on navigating treatment discussions with patients from sexual and gender minority populations with prostate cancer at #ASTRO2024
Major congrats to my friend Dr Sofia Rivera on the HypoG-01 just presented at #ESMO2024
Hypofractionation not inferior to conventional fractionation for #BreastCancer with nodal RT.
✅Similar toxicity
✅Similar efficacy (BCSM OS LRFS DMFS)
3 weeks is the way to go!
🌟 Join us for the Women in Radiation Oncology Virtual Event! 🌟
Connect with and learn from leading experts in the field. Don’t miss this opportunity to advance your career and network with peers. Register now!
#WomenInRadiationOncology#RadiationOncology#WomenInSTEM
🌟 Join us for the Women in Radiation Oncology Virtual Event! 🌟
Connect with and learn from leading experts in the field. Don’t miss this opportunity to advance your career and network with peers. Register now!
#WomenInRadiationOncology#RadiationOncology#WomenInSTEM